Search

Search results

Axxonis Pharma AG Berlin Submits A European Marketing Authorisation Application For Nenad(R) (lisuride) Transdermal Patch And Su

... Nenad(R) (lisuride transdermal patch as add-on therapy for Parkinson's Disease and for Restless Legs Syndrome, and subcutaneous (sc) lisuride infusion for advanced Parkinson's Disease) Lisuride, the active principle of Nenad(R), is a ...

Article - Anna Ohlden - Jun 4 2008 - 10:30am - 0 attachments

The Future Is Not Plastics - It's Protein Fibrils

Amyloid deposits in tissues and organs are linked to a number of diseases, including Alzheimer’s, Parkinson’s, type II diabetes, and prion diseases such as BSE. However, amyloids are not just pathological substances; they have potential as a nanomateria ...

Article - News Staff - May 28 2008 - 11:01am - 1 attachment

Striving Toward A Rational Stem Cell Research Debate

... the treatment of incurable diseases such as paraplegia and Parkinson's Disease means that we should avoid erecting blanket legal barriers, ...

Article - News Staff - May 15 2008 - 8:55pm - 0 attachments

Green Tea May Help With Sleep Apnea's Cognitive Defects

Chemicals found in green tea may be able to stave off the cognitive deficits that occur with obstructive sleep apnea (OSA), according to a new study published in the American Journal of Respiratory and Critical Care Medicine. Researchers examined th ...

Article - News Staff - May 15 2008 - 11:20am - 0 attachments

COMT Gene And Cognitive Clues To Alcohol Addiction

... might prescribe medications, such as those used to treat Parkinson's or early Alzheimer's disease, or tailor cognitive therapy to ...

Article - News Staff - Dec 26 2007 - 11:38am - 0 attachments

Genetic Variation In Mitochondria Linked To Macular Degeneration

Genetic variation in the DNA of mitochondria – the 'power plants' of cells – contributes to a person’s risk of developing age-related macular degeneration (AMD), say investigators in the first study to examine the mitochondrial genome for changes associ ...

Article - News Staff - May 6 2008 - 8:04pm - 0 attachments

Diamyd Strengthens Financial Position And Executes A Fully Subscribed Direct Placement

... has also out-licensed the use of GAD for the treatment of Parkinson's disease. Diamyd Medical has offices in Sweden and in the US. ...

Article - Anna Ohlden - Apr 21 2008 - 5:31am - 0 attachments

New Data Confirm Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Sleep Disturbance For People With Restless Legs S

... for the treatment of the signs and symptoms of idiopathic Parkinson's disease, as monotherapy or in combination with levodopa. ... most commonly reported adverse reactions in early and late Parkinson's disease in clinical trials were nausea, dyskinesia, hypotension, ...

Article - Anna Ohlden - Apr 17 2008 - 1:31am - 0 attachments

Dopamine 'mother Cells' Could Lead To Future Parkinson's Treatments

‘Mother cells’ which produce the neurons affected by Parkinson’s disease have been identified by scientists, according to new research published in the journal Glia. The new discovery could pave the way for future treatments for the disease, includ ...

Article - News Staff - Apr 7 2008 - 1:04pm - 0 attachments

Synosia Starts Phase II Efficacy Trial For Rufinamide

... with high unmet medical need, including anxiety and Parkinson's Disease. Synosia's headquarters is in Basel, Switzerland. For more ...

Article - Anna Ohlden - Mar 31 2008 - 12:33am - 0 attachments